Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v5-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2019-07-02 | 2019-07-02 |
| Drug Identification Number | 02154234 | 02154234 |
| Brand name | ACETAMINOPHEN 300 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE | ACETAMINOPHEN 300 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE |
| Common or Proper name | Acetaminophen 300 mg with 15 mg Caffeine and 8 mg Codeine Phosphate | Acetaminophen 300 mg with 15 mg Caffeine and 8 mg Codeine Phosphate |
| Company Name | LABORATOIRE RIVA INC. | LABORATOIRE RIVA INC. |
| Ingredients | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
| Strength(s) | 300MG 8MG 15MG | 300MG 8MG 15MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 30, 50, 100, 200 | 30, 50, 100, 200 |
| ATC code | N02AJ | N02AJ |
| ATC description | OPIOIDS | OPIOIDS |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2019-06-29 | 2019-06-29 |
| Remaining supply date | 2019-06-29 | 2019-06-29 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Not commercially viable. | Not commercially viable. |
| Health Canada comments |